 | • レポートコード：GIR-107A12433 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、長時間作用型インスリンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。長時間作用型インスリンの種類別市場規模（インスリングラルギン、インスリンデテミル、インスリンデグルデク、長時間作用型動物インスリン）、用途別市場規模（家庭用、医療機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・長時間作用型インスリンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novo Nordisk、Sanofi、Wockhardt UK ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：インスリングラルギン、インスリンデテミル、インスリンデグルデク、長時間作用型動物インスリン ・用途別分析2016年-2026年：家庭用、医療機関、その他 ・長時間作用型インスリンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・長時間作用型インスリンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・長時間作用型インスリンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・長時間作用型インスリンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・長時間作用型インスリンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Long Acting Insulins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Long Acting Insulins size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Long Acting Insulins market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Long Acting Insulins market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Insulin Glargine
Insulin Determir
Insulin Degludec
Long Acting Animal Insulin
Market segment by Application, can be divided into
Home Use
Medical Institutions
Others
Market segment by players, this report covers
Novo Nordisk
Sanofi
Wockhardt UK
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Long Acting Insulins
1.2 Classification of Long Acting Insulins by Type
1.2.1 Overview: Global Long Acting Insulins Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Long Acting Insulins Revenue Market Share by Type in 2020
1.2.3 Insulin Glargine
1.2.4 Insulin Determir
1.2.5 Insulin Degludec
1.2.6 Long Acting Animal Insulin
1.3 Global Long Acting Insulins Market by Application
1.3.1 Overview: Global Long Acting Insulins Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Home Use
1.3.3 Medical Institutions
1.3.4 Others
1.4 Global Long Acting Insulins Market Size & Forecast
1.5 Global Long Acting Insulins Market Size and Forecast by Region
1.5.1 Global Long Acting Insulins Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Long Acting Insulins Market Size by Region, (2016-2021)
1.5.3 North America Long Acting Insulins Market Size and Prospect (2016-2026)
1.5.4 Europe Long Acting Insulins Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Long Acting Insulins Market Size and Prospect (2016-2026)
1.5.6 South America Long Acting Insulins Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Long Acting Insulins Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Long Acting Insulins Market Drivers
1.6.2 Long Acting Insulins Market Restraints
1.6.3 Long Acting Insulins Trends Analysis
2 Company Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Long Acting Insulins Product and Solutions
2.1.4 Novo Nordisk Long Acting Insulins Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Novo Nordisk Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Long Acting Insulins Product and Solutions
2.2.4 Sanofi Long Acting Insulins Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Wockhardt UK
2.3.1 Wockhardt UK Details
2.3.2 Wockhardt UK Major Business
2.3.3 Wockhardt UK Long Acting Insulins Product and Solutions
2.3.4 Wockhardt UK Long Acting Insulins Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Wockhardt UK Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Long Acting Insulins Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Long Acting Insulins Players Market Share
3.2.2 Top 10 Long Acting Insulins Players Market Share
3.2.3 Market Competition Trend
3.3 Long Acting Insulins Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Long Acting Insulins Revenue and Market Share by Type (2016-2021)
4.2 Global Long Acting Insulins Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Long Acting Insulins Revenue Market Share by Application (2016-2021)
5.2 Long Acting Insulins Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Long Acting Insulins Revenue by Type (2016-2026)
6.2 North America Long Acting Insulins Revenue by Application (2016-2026)
6.3 North America Long Acting Insulins Market Size by Country
6.3.1 North America Long Acting Insulins Revenue by Country (2016-2026)
6.3.2 United States Long Acting Insulins Market Size and Forecast (2016-2026)
6.3.3 Canada Long Acting Insulins Market Size and Forecast (2016-2026)
6.3.4 Mexico Long Acting Insulins Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Long Acting Insulins Revenue by Type (2016-2026)
7.2 Europe Long Acting Insulins Revenue by Application (2016-2026)
7.3 Europe Long Acting Insulins Market Size by Country
7.3.1 Europe Long Acting Insulins Revenue by Country (2016-2026)
7.3.2 Germany Long Acting Insulins Market Size and Forecast (2016-2026)
7.3.3 France Long Acting Insulins Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Long Acting Insulins Market Size and Forecast (2016-2026)
7.3.5 Russia Long Acting Insulins Market Size and Forecast (2016-2026)
7.3.6 Italy Long Acting Insulins Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Long Acting Insulins Revenue by Type (2016-2026)
8.2 Asia-Pacific Long Acting Insulins Revenue by Application (2016-2026)
8.3 Asia-Pacific Long Acting Insulins Market Size by Region
8.3.1 Asia-Pacific Long Acting Insulins Revenue by Region (2016-2026)
8.3.2 China Long Acting Insulins Market Size and Forecast (2016-2026)
8.3.3 Japan Long Acting Insulins Market Size and Forecast (2016-2026)
8.3.4 South Korea Long Acting Insulins Market Size and Forecast (2016-2026)
8.3.5 India Long Acting Insulins Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Long Acting Insulins Market Size and Forecast (2016-2026)
8.3.7 Australia Long Acting Insulins Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Long Acting Insulins Revenue by Type (2016-2026)
9.2 South America Long Acting Insulins Revenue by Application (2016-2026)
9.3 South America Long Acting Insulins Market Size by Country
9.3.1 South America Long Acting Insulins Revenue by Country (2016-2026)
9.3.2 Brazil Long Acting Insulins Market Size and Forecast (2016-2026)
9.3.3 Argentina Long Acting Insulins Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Long Acting Insulins Revenue by Type (2016-2026)
10.2 Middle East & Africa Long Acting Insulins Revenue by Application (2016-2026)
10.3 Middle East & Africa Long Acting Insulins Market Size by Country
10.3.1 Middle East & Africa Long Acting Insulins Revenue by Country (2016-2026)
10.3.2 Turkey Long Acting Insulins Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Long Acting Insulins Market Size and Forecast (2016-2026)
10.3.4 UAE Long Acting Insulins Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Long Acting Insulins Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Long Acting Insulins Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Long Acting Insulins Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Long Acting Insulins Revenue (USD Million) by Region (2016-2021)
Table 5. Global Long Acting Insulins Revenue Market Share by Region (2021-2026)
Table 6. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 7. Novo Nordisk Major Business
Table 8. Novo Nordisk Long Acting Insulins Product and Solutions
Table 9. Novo Nordisk Long Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Sanofi Corporate Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Long Acting Insulins Product and Solutions
Table 13. Sanofi Long Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Wockhardt UK Corporate Information, Head Office, and Major Competitors
Table 15. Wockhardt UK Major Business
Table 16. Wockhardt UK Long Acting Insulins Product and Solutions
Table 17. Wockhardt UK Long Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Global Long Acting Insulins Revenue (USD Million) by Players (2019-2021)
Table 19. Global Long Acting Insulins Revenue Share by Players (2019-2021)
Table 20. Breakdown of Long Acting Insulins by Company Type (Tier 1, Tier 2 and Tier 3)
Table 21. Long Acting Insulins Players Head Office, Products and Services Provided
Table 22. Long Acting Insulins Mergers & Acquisitions in the Past Five Years
Table 23. Long Acting Insulins New Entrants and Expansion Plans
Table 24. Global Long Acting Insulins Revenue (USD Million) by Type (2016-2021)
Table 25. Global Long Acting Insulins Revenue Share by Type (2016-2021)
Table 26. Global Long Acting Insulins Revenue Forecast by Type (2021-2026)
Table 27. Global Long Acting Insulins Revenue by Application (2016-2021)
Table 28. Global Long Acting Insulins Revenue Forecast by Application (2021-2026)
Table 29. North America Long Acting Insulins Revenue by Type (2016-2021) & (USD Million)
Table 30. North America Long Acting Insulins Revenue by Type (2021-2026) & (USD Million)
Table 31. North America Long Acting Insulins Revenue by Application (2016-2021) & (USD Million)
Table 32. North America Long Acting Insulins Revenue by Application (2021-2026) & (USD Million)
Table 33. North America Long Acting Insulins Revenue by Country (2016-2021) & (USD Million)
Table 34. North America Long Acting Insulins Revenue by Country (2021-2026) & (USD Million)
Table 35. Europe Long Acting Insulins Revenue by Type (2016-2021) & (USD Million)
Table 36. Europe Long Acting Insulins Revenue by Type (2021-2026) & (USD Million)
Table 37. Europe Long Acting Insulins Revenue by Application (2016-2021) & (USD Million)
Table 38. Europe Long Acting Insulins Revenue by Application (2021-2026) & (USD Million)
Table 39. Europe Long Acting Insulins Revenue by Country (2016-2021) & (USD Million)
Table 40. Europe Long Acting Insulins Revenue by Country (2021-2026) & (USD Million)
Table 41. Asia-Pacific Long Acting Insulins Revenue by Type (2016-2021) & (USD Million)
Table 42. Asia-Pacific Long Acting Insulins Revenue by Type (2021-2026) & (USD Million)
Table 43. Asia-Pacific Long Acting Insulins Revenue by Application (2016-2021) & (USD Million)
Table 44. Asia-Pacific Long Acting Insulins Revenue by Application (2021-2026) & (USD Million)
Table 45. Asia-Pacific Long Acting Insulins Revenue by Region (2016-2021) & (USD Million)
Table 46. Asia-Pacific Long Acting Insulins Revenue by Region (2021-2026) & (USD Million)
Table 47. South America Long Acting Insulins Revenue by Type (2016-2021) & (USD Million)
Table 48. South America Long Acting Insulins Revenue by Type (2021-2026) & (USD Million)
Table 49. South America Long Acting Insulins Revenue by Application (2016-2021) & (USD Million)
Table 50. South America Long Acting Insulins Revenue by Application (2021-2026) & (USD Million)
Table 51. South America Long Acting Insulins Revenue by Country (2016-2021) & (USD Million)
Table 52. South America Long Acting Insulins Revenue by Country (2021-2026) & (USD Million)
Table 53. Middle East & Africa Long Acting Insulins Revenue by Type (2016-2021) & (USD Million)
Table 54. Middle East & Africa Long Acting Insulins Revenue by Type (2021-2026) & (USD Million)
Table 55. Middle East & Africa Long Acting Insulins Revenue by Application (2016-2021) & (USD Million)
Table 56. Middle East & Africa Long Acting Insulins Revenue by Application (2021-2026) & (USD Million)
Table 57. Middle East & Africa Long Acting Insulins Revenue by Country (2016-2021) & (USD Million)
Table 58. Middle East & Africa Long Acting Insulins Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Long Acting Insulins Picture
Figure 2. Global Long Acting Insulins Revenue Market Share by Type in 2020
Figure 3. Insulin Glargine
Figure 4. Insulin Determir
Figure 5. Insulin Degludec
Figure 6. Long Acting Animal Insulin
Figure 7. Long Acting Insulins Revenue Market Share by Application in 2020
Figure 8. Home Use Picture
Figure 9. Medical Institutions Picture
Figure 10. Others Picture
Figure 11. Global Long Acting Insulins Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Long Acting Insulins Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Long Acting Insulins Revenue Market Share by Region (2016-2026)
Figure 14. Global Long Acting Insulins Revenue Market Share by Region in 2020
Figure 15. North America Long Acting Insulins Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Long Acting Insulins Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Long Acting Insulins Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Long Acting Insulins Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Long Acting Insulins Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Long Acting Insulins Market Drivers
Figure 21. Long Acting Insulins Market Restraints
Figure 22. Long Acting Insulins Market Trends
Figure 23. Novo Nordisk Recent Developments and Future Plans
Figure 24. Sanofi Recent Developments and Future Plans
Figure 25. Wockhardt UK Recent Developments and Future Plans
Figure 26. Global Long Acting Insulins Revenue Share by Players in 2020
Figure 27. Long Acting Insulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 28. Global Top 3 Players Long Acting Insulins Revenue Market Share in 2020
Figure 29. Global Top 10 Players Long Acting Insulins Revenue Market Share in 2020
Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 31. Global Long Acting Insulins Revenue Share by Type in 2020
Figure 32. Global Long Acting Insulins Market Share Forecast by Type (2021-2026)
Figure 33. Global Long Acting Insulins Revenue Share by Application in 2020
Figure 34. Global Long Acting Insulins Market Share Forecast by Application (2021-2026)
Figure 35. North America Long Acting Insulins Sales Market Share by Type (2016-2026)
Figure 36. North America Long Acting Insulins Sales Market Share by Application (2016-2026)
Figure 37. North America Long Acting Insulins Revenue Market Share by Country (2016-2026)
Figure 38. United States Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Canada Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Mexico Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Europe Long Acting Insulins Sales Market Share by Type (2016-2026)
Figure 42. Europe Long Acting Insulins Sales Market Share by Application (2016-2026)
Figure 43. Europe Long Acting Insulins Revenue Market Share by Country (2016-2026)
Figure 44. Germany Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. France Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. United Kingdom Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Russia Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Italy Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Long Acting Insulins Sales Market Share by Type (2016-2026)
Figure 50. Asia-Pacific Long Acting Insulins Sales Market Share by Application (2016-2026)
Figure 51. Asia-Pacific Long Acting Insulins Revenue Market Share by Region (2016-2026)
Figure 52. China Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Japan Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. South Korea Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. India Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Southeast Asia Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Australia Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South America Long Acting Insulins Sales Market Share by Type (2016-2026)
Figure 59. South America Long Acting Insulins Sales Market Share by Application (2016-2026)
Figure 60. South America Long Acting Insulins Revenue Market Share by Country (2016-2026)
Figure 61. Brazil Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Argentina Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Middle East and Africa Long Acting Insulins Sales Market Share by Type (2016-2026)
Figure 64. Middle East and Africa Long Acting Insulins Sales Market Share by Application (2016-2026)
Figure 65. Middle East and Africa Long Acting Insulins Revenue Market Share by Country (2016-2026)
Figure 66. Turkey Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Saudi Arabia Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. UAE Long Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Methodology
Figure 70. Research Process and Data Source
世界の速効型インスリン市場 2021：企業別、地域別、種類・用途別 The Rapid Acting Insulins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…- 世界の人間インスリン治療薬＆デリバリーデバイス市場 2021：企業別、地域別、種類・用途別 The Human Insulin Drugs And Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 世界の反転型ラプチャーディスク市場 2021：企業別、地域別、種類・用途別 The Reverse Acting Rupture Discs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の自己作動式温度制御バルブ市場 2021：企業別、地域別、種類・用途別 The Self Acting Temperature Control Valves market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 世界の間接作動圧力計市場 2021：企業別、地域別、種類・用途別 The Indirect Acting Pressure Gauge market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …